169 related articles for article (PubMed ID: 26332786)
21. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
[TBL] [Abstract][Full Text] [Related]
22. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792
[TBL] [Abstract][Full Text] [Related]
24. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
25. A close surgical margin after radical prostatectomy is an independent predictor of recurrence.
Lu J; Wirth GJ; Wu S; Chen J; Dahl DM; Olumi AF; Young RH; McDougal WS; Wu CL
J Urol; 2012 Jul; 188(1):91-7. PubMed ID: 22578729
[TBL] [Abstract][Full Text] [Related]
26. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
27. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
28. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
[TBL] [Abstract][Full Text] [Related]
29. miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer.
Li T; Li RS; Li YH; Zhong S; Chen YY; Zhang CM; Hu MM; Shen ZJ
J Urol; 2012 Apr; 187(4):1466-72. PubMed ID: 22341810
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
31. Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.
Caso JR; Tsivian M; Mouraviev V; Polascik TJ; Moul JW
BJU Int; 2010 Dec; 106(11):1623-7. PubMed ID: 20553260
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
Braadland PR; Giskeødegård G; Sandsmark E; Bertilsson H; Euceda LR; Hansen AF; Guldvik IJ; Selnæs KM; Grytli HH; Katz B; Svindland A; Bathen TF; Eri LM; Nygård S; Berge V; Taskén KA; Tessem MB
Br J Cancer; 2017 Nov; 117(11):1656-1664. PubMed ID: 28972967
[TBL] [Abstract][Full Text] [Related]
33. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
35. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.
Ramos CG; Roehl KA; Antenor JA; Humphrey PA; Catalona WJ
J Urol; 2004 Jul; 172(1):137-40. PubMed ID: 15201754
[TBL] [Abstract][Full Text] [Related]
36. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy.
Tilki D; Mandel P; Seeliger F; Kretschmer A; Karl A; Ergün S; Seitz M; Stief CG
J Urol; 2015 Feb; 193(2):484-90. PubMed ID: 25180792
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.
Hashimoto K; Masumori N; Takei F; Fukuta F; Takahashi A; Itoh N; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2008 Jan; 38(1):31-5. PubMed ID: 18203710
[TBL] [Abstract][Full Text] [Related]
38. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
39. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.
Freedland SJ; deGregorio F; Sacoolidge JC; Elshimali YI; Csathy GS; Dorey F; Reiter RE; Aronson WJ
J Urol; 2003 Apr; 169(4):1325-30. PubMed ID: 12629353
[TBL] [Abstract][Full Text] [Related]
40. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
